Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis

Routine noninvasive prenatal screening for fetal RHD in plasma of RhD‐negative pregnant women—2 years of screening experience from Denmark

High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery

Next‐generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell‐free fetal DNA in maternal plasma

Noninvasive fetal RhD genotyping

Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit